{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:19:17Z","timestamp":1790518757304,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajogmf.2022.100676","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T23:12:41Z","timestamp":1655248361000},"page":"100676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Universal first-trimester cytomegalovirus screening and valaciclovir prophylaxis in pregnant persons: a cost-effectiveness analysis"],"prefix":"10.1016","volume":"4","author":[{"given":"Stephanie A.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Grobman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2022.100676_bib0001","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0002","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jpids\/piy027","article-title":"The burden of congenital cytomegalovirus infection: a prospective cohort study of 20 000 infants in Finland","volume":"8","author":"Puhakka","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0003","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/600882","article-title":"Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population","volume":"49","author":"Mussi-Pinhata","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl4","key":"10.1016\/j.ajogmf.2022.100676_bib0004","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jcv.2009.09.002","article-title":"Congenital cytomegalovirus (CMV) epidemiology and awareness","volume":"46","author":"Cannon","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajog.2020.02.018","article-title":"Cytomegalovirus infection during pregnancy: state of the science","volume":"223","author":"Leruez-Ville","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0006","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cid\/cix337","article-title":"Risk factors for congenital cytomegalovirus infection following primary and nonprimary maternal infection: a prospective neonatal screening study using polymerase chain reaction in saliva","volume":"65","author":"Leruez-Ville","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0007","series-title":"Infectious diseases of the fetus and newborn infant","first-page":"706","article-title":"Cytomegalovirus","author":"Britt","year":"2011"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0008","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0002-9378(88)90252-9","article-title":"Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants","volume":"158","author":"Yow","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.05.038","article-title":"Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences","volume":"223","author":"Chatzakis","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0010","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2016.02.042","article-title":"Diagnosis and antenatal management of congenital cytomegalovirus infection","volume":"214","author":"Hughes","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0011","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1913569","article-title":"A trial of hyperimmune globulin to prevent congenital cytomegalovirus infection","volume":"385","author":"Hughes","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0928-0197(97)10016-2","article-title":"Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women","volume":"9","author":"Bod\u00e9us","year":"1998","journal-title":"Clin Diagn Virol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0013","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcv.2005.09.011","article-title":"Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples","volume":"35","author":"Dangel","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0014","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/pd.1001","article-title":"A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women","volume":"24","author":"Mac\u00e9","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/vim.2000.13.137","article-title":"Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus","volume":"13","author":"Lazzarotto","year":"2000","journal-title":"Viral Immunol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.07.056","article-title":"Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis","volume":"201","author":"Cahill","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1471-0528.16966","article-title":"Leaning towards cytomegalovirus serological screening in pregnancy to prevent congenital infection: a cost-effectiveness perspective","volume":"129","author":"Seror","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0018","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ajog.2006.09.020","article-title":"A thoughtful algorithm for the accurate diagnosis of primary CMV infection in pregnancy","volume":"196","author":"Duff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0019","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/uog.23685","article-title":"Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy","volume":"58","author":"Faure-Bardon","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0021","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0022","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1055\/s-0038-1676495","article-title":"Cytomegalovirus screening in pregnancy: a cost-effectiveness and threshold analysis","volume":"36","author":"Albright","year":"2019","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.01.032","article-title":"The cost-effectiveness of prenatal screening for spinal muscular atrophy","volume":"202","author":"Little","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225281","article-title":"Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: a microsimulation modeling analysis","volume":"14","author":"Zhang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS)\u2013explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0026","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0272989X12454577","article-title":"ISPOR-SMDM Modeling Good Research Practices Task Force. Modeling good research practices\u2013overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1","volume":"32","author":"Caro","year":"2012","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0027","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/513996","article-title":"Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women","volume":"175","author":"Grangeot-Keros","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0028","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/CDLI.6.1.127-129.1999","article-title":"Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection","volume":"6","author":"Lazzarotto","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0029","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0031","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejogrb.2020.12.006","article-title":"Cytomegalovirus infection in pregnancy - an update","volume":"258","author":"Navti","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0032","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/pd.5107","article-title":"Amniocentesis for prenatal diagnosis of cytomegalovirus infection: challenging the 21 weeks\u2019 threshold","volume":"37","author":"Enders","year":"2017","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0033","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/JCM.01576-08","article-title":"Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples","volume":"47","author":"Goegebuer","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0034","first-page":"881","article-title":"Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk","volume":"95","author":"Liesnard","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0035","first-page":"443","article-title":"Prenatal diagnosis of congenital cytomegalovirus infection","volume":"97","author":"Azam","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0036","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cid\/ciw237","article-title":"Clinical implications for children born with congenital cytomegalovirus infection following a negative amniocentesis","volume":"63","author":"Bilavsky","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0037","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.05.010","article-title":"Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction","volume":"223","author":"Martins","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0038","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/uog.21946","article-title":"Revisiting short- and long-term outcome after fetal first-trimester primary cytomegalovirus infection in relation to prenatal imaging findings","volume":"56","author":"Lipitz","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0039","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00431-002-1115-5","article-title":"Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature","volume":"162","author":"Gaytant","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0041","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006254-200204000-00024","article-title":"Congenital cytomegalovirus infection: review of the epidemiology and outcome","volume":"57","author":"Gaytant","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0042","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1471-0528.2003.02021.x","article-title":"Birth outcomes: utility values that postnatal women, midwives and medical staff express","volume":"110","author":"Pham","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0043","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1523-536x.1999.00178.x","article-title":"Differences in the valuation of birth outcomes among pregnant women, mothers, and obstetricians","volume":"26","author":"Vandenbussche","year":"1999","journal-title":"Birth"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0044","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/AOG.0000000000001029","article-title":"Prenatal testing in the genomic age: clinical outcomes, quality of life, and costs","volume":"126","author":"Kaimal","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pd.4808","article-title":"Preferences regarding contemporary prenatal genetic tests among women desiring testing: implications for optimal testing strategies","volume":"36","author":"Kuppermann","year":"2016","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0046","first-page":"511","article-title":"Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences","volume":"96","author":"Kuppermann","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0047","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.contraception.2004.03.008","article-title":"Costs and net health effects of contraceptive methods","volume":"69","author":"Sonnenberg","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0048","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2009.01.040","article-title":"Improving decision analyses: parent preferences (utility values) for pediatric health outcomes","volume":"155","author":"Carroll","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0049","first-page":"1","article-title":"Births: final data for 2019","volume":"70","author":"Martin","year":"2021","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0050","first-page":"1","article-title":"Deaths: final data for 2018","volume":"69","author":"Murphy","year":"2021","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0051","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00005650-200006000-00004","article-title":"One thousand health-related quality-of-life estimates","volume":"38","author":"Tengs","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0052","series-title":"Vaccines for the 21st century: a tool for decisionmaking","year":"2000"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0053","series-title":"Consumer price index","year":"2021"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0054","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1996.03540160061034","article-title":"Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine","volume":"276","author":"Siegel","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1099-176X(199903)2:1<43::AID-MHP36>3.0.CO;2-7","article-title":"Methods for the economic evaluation of health care programmes, second edition. By Michael F. Drummond, Bernie O'Brien, Greg L. Stoddart, George W. Torrance. Oxford: Oxford University Press, 1997","volume":"2","author":"Cartwright","year":"1999","journal-title":"J Ment Health Policy Econ"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0056","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1037\/0278-6133.1.1.61","article-title":"Health-related quality of life measurement for evaluation research and policy analysis","volume":"1","author":"Kaplan","year":"1982","journal-title":"Health Psychol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0057","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2018.1447828","article-title":"On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review","volume":"11","author":"Cameron","year":"2018","journal-title":"Glob Health Action"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0058","first-page":"4","article-title":"Creating decision trees to assess cost-effectiveness in clinical research","volume":"7","author":"Werner","year":"2012","journal-title":"J Biom Biostat"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0059","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/0272989X0002000310","article-title":"Willingness to pay for a quality-adjusted life year: in search of a standard","volume":"20","author":"Hirth","year":"2000","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0060","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0061","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000518508","article-title":"Serial monitoring and hyperimmunoglobulin versus standard of care to prevent congenital cytomegalovirus infection: a phase III randomized trial","volume":"48","author":"Devlieger","year":"2021","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0062","first-page":"73","article-title":"A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection","volume":"95","year":"2012","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0063","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.692226","article-title":"Prevalence and recurrence rates of cytomegalovirus infection among patients with hematological diseases in the Western Brazilian Amazon: a cross-sectional study","volume":"9","author":"de Melo Silva","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0065","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1017\/S0950268817000103","article-title":"Seroprevalence of cytomegalovirus infection in France in 2010","volume":"145","author":"Antona","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0066","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0067","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2018.1150","article-title":"Health care spending in the United States and other high-income countries","volume":"319","author":"Papanicolas","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0068","unstructured":"Dutton PV. Health care in France and the United States: learning from each other. 2002. Available at:https:\/\/www.brookings.edu\/articles\/health-care-in-france-and-the-united-states-learning-from-each-other\/. Accessed April 23, 2022."},{"key":"10.1016\/j.ajogmf.2022.100676_bib0070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajog.2004.10.600","article-title":"Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis","volume":"192","author":"Plunkett","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0071","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/AOG.0000000000003062","article-title":"Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care","volume":"133","author":"Tasillo","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0072","series-title":"Principles and practice of screening for disease","author":"Wilson","year":"1968"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0073","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2334-7-71","article-title":"Incidence of cytomegalovirus infection among the general population and pregnant women in the United States","volume":"7","author":"Colugnati","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0074","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/rmv.659","article-title":"Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV","volume":"20","author":"Hyde","year":"2010","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0076","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1089\/jwh.2006.15.224","article-title":"The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup","volume":"15","author":"Ross","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0077","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jcv.2007.10.015","article-title":"New advances in the diagnosis of congenital cytomegalovirus infection","volume":"41","author":"Lazzarotto","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0078","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.humimm.2004.02.006","article-title":"Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection","volume":"65","author":"Lazzarotto","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0079","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0002-9378(94)70040-0","article-title":"A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group","volume":"171","author":"Crane","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0080","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/pd.2762","article-title":"Comparison of prevalence of toxoplasma and cytomegalovirus infection in cases with fetal ultrasound markers in the second trimester of pregnancy","volume":"31","author":"Beke","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.09.052","article-title":"Ultrasound prediction of symptomatic congenital cytomegalovirus infection","volume":"198","author":"Guerra","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0082","first-page":"64","article-title":"Routine obstetrical ultrasound at 18-22 weeks: our experience on 7,236 fetuses","volume":"8","author":"Stefos","year":"1999","journal-title":"J Matern Fetal Med"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0083","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9378(99)70577-6","article-title":"The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study","volume":"181","author":"Grandjean","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0084","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.siny.2017.11.005","article-title":"First and second trimester screening for fetal structural anomalies","volume":"23","author":"Edwards","year":"2018","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/aogs.13037","article-title":"Detection of fetal abnormalities by second-trimester ultrasound screening in a non-selected population","volume":"96","author":"Rydberg","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0086","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14767058.2017.1387890","article-title":"Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid","volume":"32","author":"Bl\u00e1zquez-Gamero","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0087","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1469-0705.1995.05030174.x","article-title":"Routine prenatal ultrasound screening for fetal abnormalities: 22 years\u2019 experience","volume":"5","author":"Carrera","year":"1995","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.08.039","article-title":"Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers","volume":"196","author":"Guerra","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0089","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0002-9378(93)90605-I","article-title":"A randomized trial of prenatal ultrasonographic screening: impact on maternal management and outcome. RADIUS (Routine Antenatal Diagnostic Imaging with Ultrasound) Study Group","volume":"169","author":"LeFevre","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/uog.20353","article-title":"Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis","volume":"54","author":"Salomon","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0091","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/AOG.0b013e318162eb53","article-title":"Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience","volume":"111","author":"Odibo","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0092","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.AOG.0000240135.13594.07","article-title":"Pregnancy loss rates after midtrimester amniocentesis","volume":"108","author":"Eddleman","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0093","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/01.AOG.0000278820.54029.e3","article-title":"Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review","volume":"110","author":"Mujezinovic","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0094","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcv.2010.12.012","article-title":"Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience","volume":"50","author":"Revello","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0095","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00003081-199309000-00008","article-title":"Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results","volume":"36","author":"Pryde","year":"1993","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0096","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cid\/cis423","article-title":"Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age","volume":"55","author":"Visentin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0097","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000510816","article-title":"Impact of the Israeli Ministry of Health cytomegalovirus guidelines on the local pregnancy outcome","volume":"48","author":"Pekar-Zlotin","year":"2021","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0098","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/uog.6446","article-title":"Diagnostic performance of routine ultrasound screening for fetal abnormalities in an unselected Swedish population in 2000-2005","volume":"34","author":"Romosan","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0099","first-page":"1","article-title":"Lack of change in perinatal mortality in the United States, 2014-2016","author":"Gregory","year":"2018","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0100","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1542\/peds.2006-1729","article-title":"Preterm birth-associated cost of early intervention services: an analysis by gestational age","volume":"119","author":"Clements","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.earlhumdev.2006.01.001","article-title":"Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants","volume":"82","author":"Phibbs","year":"2006","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0102","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199904223401603","article-title":"Birth weight in relation to morbidity and mortality among newborn infants","volume":"340","author":"McIntire","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0103","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1067\/mob.2001.109735","article-title":"Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies","volume":"184","author":"Smith","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0104","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0105","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/171.5.1115","article-title":"Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection","volume":"171","author":"Boppana","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0106","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpeds.2004.05.041","article-title":"Prevention of child-to-mother transmission of cytomegalovirus among pregnant women","volume":"145","author":"Adler","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0107","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.289.8.1008","article-title":"Maternal immunity and prevention of congenital cytomegalovirus infection","volume":"289","author":"Fowler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0108","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/uog.23143","article-title":"Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: systematic review and meta-analysis","volume":"57","author":"Buca","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0109","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00007890-200011270-00012","article-title":"Valaciclovir prophylaxis of cytomegalovirus infection and disease in renal transplantation: an economic evaluation","volume":"70","author":"Legendre","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0110","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000335962","article-title":"Pharmacoeconomic impact of different regimens to prevent cytomegalovirus infection in renal transplant recipients","volume":"35","author":"Kielberger","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0111","unstructured":"Drugs.com. Valacyclovir prices, coupons and patient assistance programs. Available at: https:\/\/www.drugs.com\/price-guide\/valacyclovir. Accessed November 3, 2021."},{"key":"10.1016\/j.ajogmf.2022.100676_bib0112","unstructured":"Drug identification results \u2013 Valtrex. IBM Micromedex. <https:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/BF0004\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/646879\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.GoToDashboard?docId=923398&contentSetId=100&title=Valacyclovir+Hydrochloride&servicesTitle=Valacyclovir+Hydrochloride&brandName=Valtrex&UserMdxSearchTerm=valtrex&=null#>. Accessed November 3, 2021."},{"key":"10.1016\/j.ajogmf.2022.100676_bib0113","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0140-6736(03)15385-8","article-title":"Cost utility of prenatal diagnosis and the risk-based threshold","volume":"363","author":"Harris","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0114","unstructured":"American College of Radiology. Medicare physician fee schedule. Available at:https:\/\/www.acr.org\/Advocacy-and-Economics\/Radiology-Economics\/Medicare-Medicaid\/MPFS. Accessed November 3, 2021."},{"key":"10.1016\/j.ajogmf.2022.100676_bib0115","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1067\/mob.2002.127144","article-title":"Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis","volume":"187","author":"Caughey","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0116","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ajog.2005.09.003","article-title":"Cost-effectiveness of dilation and evacuation versus the induction of labor for second-trimester pregnancy termination","volume":"194","author":"Cowett","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0117","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s10995-012-1203-8","article-title":"Hospital costs associated with stillbirth delivery","volume":"17","author":"Gold","year":"2013","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0118","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2011.11.044","article-title":"A cost-effectiveness analysis of surgical versus medical management of early pregnancy loss","volume":"97","author":"Rausch","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0119","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1067\/S0002-9378(03)00717-8","article-title":"Prenatal cystic fibrosis screening in Mexican Americans: an economic analysis","volume":"189","author":"Doyle","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0120","first-page":"488","article-title":"The cost of prematurity: quantification by gestational age and birth weight","volume":"102","author":"Gilbert","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0121","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1016\/j.vaccine.2012.04.011","article-title":"Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus","volume":"30","author":"Dempsey","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0122","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12962-019-0189-0","article-title":"A framework for assessing the lifetime economic burden of congenital cytomegalovirus in the United States","volume":"17","author":"Lucas","year":"2019","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0123","first-page":"188","article-title":"Estimates of the economic costs of birth defects","volume":"31","author":"Waitzman","year":"1994","journal-title":"Inquiry"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0124","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1017\/S0266462300103162","article-title":"The societal costs of severe to profound hearing loss in the United States","volume":"16","author":"Mohr","year":"2000","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.ajogmf.2022.100676_bib0125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1542\/peds.110.5.855","article-title":"Projected cost-effectiveness of statewide universal newborn hearing screening","volume":"110","author":"Keren","year":"2002","journal-title":"Pediatrics"}],"container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933322001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933322001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:50:07Z","timestamp":1762905007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933322001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":124,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2589933322001112"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100676","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Universal first-trimester cytomegalovirus screening and valaciclovir prophylaxis in pregnant persons: a cost-effectiveness analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100676"}}